Latest IPO
Aspen Neuroscience, Inc.
- Offered9,375,000 sharesChecked
- Price per share$15.00Checked
- Raised$140,625,000before fees and costsChecked
Open the page for the sources.See every term
Recently priced IPOs
Newest first. Open one to see every term and where it came from.
| Company | Price | Shares sold | Raised | Filed |
|---|---|---|---|---|
| Aspen Neuroscience, Inc.ASPE, Nasdaq Global Select Market | $15.00 | 9,375,000 | $140.6 million | Oct 30 |
| Bambusa Therapeutics, Inc.BBTX, Nasdaq Global Select Market | $16.00 | 10,555,555 | $168.9 million | Oct 30 |
| Lycia Therapeutics, Inc.LYCA, Nasdaq Global Select Market | $18.00 | 17,640,000 | $317.5 million | Oct 23 |
| CITY THERAPEUTICS, INC.CTY, Nasdaq Global Market | $18.00 | 11,111,111 | $200.0 million | Oct 16 |
| Amaero Inc.AMRO | $4.25 | 4,705,883 | $20.0 million | Oct 15 |
| Iambic Therapeutics, Inc.IAM, Nasdaq Global Select Market | $16.00 | 9,375,000 | $150.0 million | Oct 15 |
| Retension Pharmaceuticals, Inc.RTSN, Nasdaq Capital Market | $12.00 | 3,750,000 | $45.0 million | Oct 9 |
| TRex Bio, Inc.TRXB, Nasdaq Global Select Market | $14.00 | 8,333,334 | $116.7 million | Oct 9 |
Filed, not yet priced
Very large or widely followed companies that have filed to go public. No price or size until a filing states one.
- Anthropic, PBCNot priced yetLatest filing: S-1 on October 26, 2026
What the numbers mean
New to IPOs? These terms cover most of a deal page.
- Offered
- How many shares the company, and sometimes its early owners, sell to the public in the IPO.
- Price per share
- What each share sold for in the IPO. This is not the price the stock trades at once it is listed.
- Raised
- Shares offered times price per share. The company does not keep all of it: banks and other costs come out first.
- Bank fee
- What the banks that run the IPO keep for selling the shares, also called the underwriting discount.
- Lead banks
- The banks that organize the IPO and sell the shares to investors. They are named on the front of the prospectus.
If we can’t back a number up, we leave it out
Every figure on a page has one of these labels and a source you can open.
Checked
Read from the filing, and the arithmetic holds: shares times price equals the total.
From the prospectus
Taken from the document, but the SEC’s own data cannot confirm it yet. We say so on the page.
Not shown
We could not find it with confidence, so there is no number. A blank beats a wrong answer.